Efficacy of Subcutaneous Interferon Β-1a in Patients with a First Clinical Demyelinating Event in REFLEX is Maintained After Application of the 2017 McDonald Criteria

Authors
Category Primary study
JournalMultiple Sclerosis and Related Disorders
Year 2020
This article has no abstract
Epistemonikos ID: 21c0dec79da7089f174c2935685a12f7cd5c4ae4
First added on: Mar 31, 2022